<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01939080</url>
  </required_header>
  <id_info>
    <org_study_id>12/B/01</org_study_id>
    <secondary_id>2012-A00359-34</secondary_id>
    <nct_id>NCT01939080</nct_id>
  </id_info>
  <brief_title>Variation of Aortic Compliance Related to Exercise Training With or Without Supervised Sessions</brief_title>
  <acronym>ACT</acronym>
  <official_title>Exercise Training in Patients With Cardiovascular Risk: Predictability of Aortic Compliance Normalization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Center of Martinique</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Center of Martinique</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many conditions and cardiovascular diseases (including stroke) are better managed with
      regular exercise training. The expected effects are partial reversal of adverse effects on
      heart and blood vessel structure and function, improved glycemic, tension and weight control.

      Physiologically, the aorta maintains low left ventricular after-load, promotes optimal
      sub-endocardial coronary blood flow, and transforms pulsatile into laminar blood flow.
      Increased aortic stiffness may ultimately contribute to left ventricular dysfunction. Regular
      exercise training is likely to decrease the pulse wave velocity (a measure of the aortic
      compliance). Some subjects seem more responsive than others, and they may not expect the same
      benefit of exercise training. To the best of our knowledge, this has not been explained yet.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">August 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pulse wave velocity</measure>
    <time_frame>With or without the exercise training</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate variability</measure>
    <time_frame>within 12 weeks after exercise training</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">308</enrollment>
  <condition>Cardiovascular Disease</condition>
  <arm_group>
    <arm_group_label>Medical supervision</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Exercise training with supervised sessions Classics training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No medical supervision</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Exercise training without supervised sessions Classics training</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Exercise training with supervised sessions</intervention_name>
    <arm_group_label>Medical supervision</arm_group_label>
    <arm_group_label>No medical supervision</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients aged 50-69 years, with moderate or high cardiovascular risk

        Exclusion Criteria:

          -  any physical or medical problem liable to limit the patient' ability to perform the
             cardiopulmonary exercise testing or the exercise training in safe conditions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Armelle JEAN-ETIENNE, MD</last_name>
    <email>Armelle.Jean-Etienne@chu-fortdefrance.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Pointe à Pitre</name>
      <address>
        <city>Pointe à Pitre</city>
        <country>Guadeloupe</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sophie ANTOINE-JONVILLE, Ph.D.</last_name>
      <email>s_antoine@ymail.com</email>
    </contact>
    <investigator>
      <last_name>Cosmin ALECU, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Annie LANNUZEL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne BLANCHET, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rachel BILLY-BRISSAC, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick FOUCAN, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Fort de France</name>
      <address>
        <city>Fort de France</city>
        <country>Martinique</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Armelle JEAN-ETIENNE, MD</last_name>
      <email>Armelle.Jean-Etienne@chu-fortdefrance.fr</email>
    </contact>
    <investigator>
      <last_name>Patrick RENE-CORAIL, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jocelyn INAMO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane OLINDO, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Guadeloupe</country>
    <country>Martinique</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2013</study_first_submitted>
  <study_first_submitted_qc>September 5, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2013</study_first_posted>
  <last_update_submitted>August 17, 2016</last_update_submitted>
  <last_update_submitted_qc>August 17, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 18, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>moderate risk</keyword>
  <keyword>high risk</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

